She received her Master and PhD degree in Critical Care Medicine in 2007 and also a holder of a master degree in pharmacovigilance and epidemiology from 7 affiliated European Universities under the EU2p Program. She is a true pioneer in her field and an author of many scientific publications. Her role focuses on being a medical advisor to healthcare providers, industry and regulatory agencies. Her priority is Post- Market drug surveillance relating to the collection, detection, assessment, monitoring and prevention of adverse effects with pharmaceutical products.